These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 14557490)

  • 1. ONYX-015 enhances radiation-induced death of human anaplastic thyroid carcinoma cells.
    Portella G; Pacelli R; Libertini S; Cella L; Vecchio G; Salvatore M; Fusco A
    J Clin Endocrinol Metab; 2003 Oct; 88(10):5027-32. PubMed ID: 14557490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ONYX-015, an E1B gene-defective adenovirus, induces cell death in human anaplastic thyroid carcinoma cell lines.
    Portella G; Scala S; Vitagliano D; Vecchio G; Fusco A
    J Clin Endocrinol Metab; 2002 Jun; 87(6):2525-31. PubMed ID: 12050209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ONYX-411, a conditionally replicative oncolytic adenovirus, induces cell death in anaplastic thyroid carcinoma cell lines and suppresses the growth of xenograft tumors in nude mice.
    Reddi HV; Madde P; Reichert-Eberhardt AJ; Galanis EC; Copland JA; McIver B; Grebe SK; Eberhardt NL
    Cancer Gene Ther; 2008 Nov; 15(11):750-7. PubMed ID: 18583996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lovastatin enhances the replication of the oncolytic adenovirus dl1520 and its antineoplastic activity against anaplastic thyroid carcinoma cells.
    Libertini S; Iacuzzo I; Ferraro A; Vitale M; Bifulco M; Fusco A; Portella G
    Endocrinology; 2007 Nov; 148(11):5186-94. PubMed ID: 17690162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Manumycin enhances the cytotoxic effect of paclitaxel on anaplastic thyroid carcinoma cells.
    Yeung SC; Xu G; Pan J; Christgen M; Bamiagis A
    Cancer Res; 2000 Feb; 60(3):650-6. PubMed ID: 10676649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potentiation of radiation therapy by the oncolytic adenovirus dl1520 (ONYX-015) in human malignant glioma xenografts.
    Geoerger B; Grill J; Opolon P; Morizet J; Aubert G; Lecluse Y; van Beusechem VW; Gerritsen WR; Kirn DH; Vassal G
    Br J Cancer; 2003 Aug; 89(3):577-84. PubMed ID: 12888833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenovirus-mediated tumor suppressor p53 gene therapy for anaplastic thyroid carcinoma in vitro and in vivo.
    Nagayama Y; Yokoi H; Takeda K; Hasegawa M; Nishihara E; Namba H; Yamashita S; Niwa M
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4081-6. PubMed ID: 11095436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncolytic activity of the E1B-55 kDa-deleted adenovirus ONYX-015 is independent of cellular p53 status in human malignant glioma xenografts.
    Geoerger B; Grill J; Opolon P; Morizet J; Aubert G; Terrier-Lacombe MJ; Bressac De-Paillerets B; Barrois M; Feunteun J; Kirn DH; Vassal G
    Cancer Res; 2002 Feb; 62(3):764-72. PubMed ID: 11830531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bevacizumab increases viral distribution in human anaplastic thyroid carcinoma xenografts and enhances the effects of E1A-defective adenovirus dl922-947.
    Libertini S; Iacuzzo I; Perruolo G; Scala S; Ieranò C; Franco R; Hallden G; Portella G
    Clin Cancer Res; 2008 Oct; 14(20):6505-14. PubMed ID: 18927290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ONYX-015 works synergistically with chemotherapy in lung cancer cell lines and primary cultures freshly made from lung cancer patients.
    You L; Yang CT; Jablons DM
    Cancer Res; 2000 Feb; 60(4):1009-13. PubMed ID: 10706117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Paclitaxel and combination of the drug with radiation therapy in an in vivo model of anaplastic thyroid carcinoma.
    Pushkarev VM; Starenki DV; Saenko VO; Tronko MD; Yamashita S
    Exp Oncol; 2011 Mar; 33(1):24-7. PubMed ID: 21423091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combretastatin A4 phosphate has primary antineoplastic activity against human anaplastic thyroid carcinoma cell lines and xenograft tumors.
    Dziba JM; Marcinek R; Venkataraman G; Robinson JA; Ain KB
    Thyroid; 2002 Dec; 12(12):1063-70. PubMed ID: 12593719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenovirus-mediated siRNA targeting NOB1 inhibits tumor growth and enhances radiosensitivity of human papillary thyroid carcinoma in vitro and in vivo.
    Meng W; Wang PS; Liu J; Xue S; Wang GM; Meng XY; Chen G
    Oncol Rep; 2014 Dec; 32(6):2411-20. PubMed ID: 25231838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistent replication of the modified chimeric adenovirus ONYX-015 in both tumor and stromal cells from a patient with gall bladder carcinoma implants.
    Wadler S; Yu B; Tan JY; Kaleya R; Rozenblit A; Makower D; Edelman M; Lane M; Hyjek E; Horwitz M
    Clin Cancer Res; 2003 Jan; 9(1):33-43. PubMed ID: 12538449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic anticancer activity of sorafenib, paclitaxel, and radiation therapy on anaplastic thyroid cancer in vitro and in vivo.
    Kim SY; Kim SM; Chang H; Chang HS; Park CS; Lee YS
    Head Neck; 2020 Dec; 42(12):3678-3684. PubMed ID: 32896015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase II clinical trial of intralesional administration of the oncolytic adenovirus ONYX-015 in patients with hepatobiliary tumors with correlative p53 studies.
    Makower D; Rozenblit A; Kaufman H; Edelman M; Lane ME; Zwiebel J; Haynes H; Wadler S
    Clin Cancer Res; 2003 Feb; 9(2):693-702. PubMed ID: 12576437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AZD1152 negatively affects the growth of anaplastic thyroid carcinoma cells and enhances the effects of oncolytic virus dl922-947.
    Libertini S; Abagnale A; Passaro C; Botta G; Barbato S; Chieffi P; Portella G
    Endocr Relat Cancer; 2011 Feb; 18(1):129-41. PubMed ID: 21071467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidermal growth factor receptor (EGFR) is overexpressed in anaplastic thyroid cancer, and the EGFR inhibitor gefitinib inhibits the growth of anaplastic thyroid cancer.
    Schiff BA; McMurphy AB; Jasser SA; Younes MN; Doan D; Yigitbasi OG; Kim S; Zhou G; Mandal M; Bekele BN; Holsinger FC; Sherman SI; Yeung SC; El-Naggar AK; Myers JN
    Clin Cancer Res; 2004 Dec; 10(24):8594-602. PubMed ID: 15623643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A hepatocellular carcinoma-specific adenovirus variant, CV890, eliminates distant human liver tumors in combination with doxorubicin.
    Li Y; Yu DC; Chen Y; Amin P; Zhang H; Nguyen N; Henderson DR
    Cancer Res; 2001 Sep; 61(17):6428-36. PubMed ID: 11522637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ionizing radiation enhances dl922-947-mediated cell death of anaplastic thyroid carcinoma cells.
    Passaro C; Abagnale A; Libertini S; Volpe M; Botta G; Cella L; Pacelli R; Halldèn G; Gillespie D; Portella G
    Endocr Relat Cancer; 2013 Oct; 20(5):633-47. PubMed ID: 23839822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.